Positive interim analysis supports continuation of Phase III insomnia trial
Avecho has announced that the planned interim analysis supports continuation of its pivotal Phase III trial of its TPM®-enhanced cannabidiol soft-gel capsule for insomnia.
Avecho has announced that the planned interim analysis supports continuation of its pivotal Phase III trial of its TPM®-enhanced cannabidiol soft-gel capsule for insomnia.